Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Pancreatic Neoplasms 114Urinary Bladder Neoplasms 56Carcinoma, Non-Small-Cell Lung 53Cholangiocarcinoma 32Biliary Tract Neoplasms 31Neoplasm Metastasis 30Ovarian Neoplasms 29Lymphoma, Large B-Cell, Diffuse 27Breast Neoplasms 25Neoplasms 24Lung Neoplasms 24Carcinoma, Transitional Cell 23Triple Negative Breast Neoplasms 22Nasopharyngeal Carcinoma 21Colorectal Neoplasms 20Non-Muscle Invasive Bladder Neoplasms 19Recurrence 17Fallopian Tube Neoplasms 16Gallbladder Neoplasms 15Sarcoma 13Bile Duct Neoplasms 11Parkinson Disease 4, Autosomal Dominant Lewy Body 10Hodgkin Disease 10Lymphoma 9Adenocarcinoma 9Uterine Cervical Neoplasms 8Stomach Neoplasms 7Lymphoma, Non-Hodgkin 7Endometrial Neoplasms 7Nasopharyngeal Neoplasms 6

Interventions

Bevacizumab 67atezolizumab 53durvalumab 43lenvatinib 42Nivolumab 37pembrolizumab 35tremelimumab 29Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 16Ipilimumab 15Sorafenib 14regorafenib 13Radiosurgery 13cabozantinib 12Radiotherapy 12apatinib 10Immunoglobulin G 10Blood Specimen Collection 10Immune Checkpoint Inhibitors 9Disulfides 9camrelizumab 8X-Rays 8Cyclophosphamide 8Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7donafenib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Gemcitabine × 1 year × Clear all
NCT03017326 2026-05-13

PHITT

University of Birmingham

Phase 3 Active not recruiting
450 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Hepatoblastoma

NCT05775159 2026-04-17

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

AstraZeneca

Phase 2 Recruiting
294 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

NCT05007106 2025-08-14

KEYVIBE-005

Merck Sharp & Dohme LLC

Phase 2 Completed
613 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡